Issue
Myricitrin regulates proliferation, apoptosis and inflammation of chondrocytes treated with IL-1β
Corresponding Author(s) : Xiao-Feng Wang
Cellular and Molecular Biology,
Vol. 66 No. 1: Issue 1
Abstract
Osteoarthritis (OA) is a clinical disease which seriously affects the quality of life of sufferers. Although the pathogenesis of OA has not been fully unraveled, it is may be due to increased levels of pro-inflammatory cytokines, activation of inflammation-related signaling pathways, and degradation of extracellular matrix. Osteoarthritis is characterized by chronic joint pain, swelling, stiffness, limited movement or joint deformity, all of which seriously affect the quality of life and health of the affected individuals. Myroside (Myr) is a polyphenolic hydroxyflavone glycoside extracted from the fruits, bark and leaves of myroside and other natural plants. It has many pharmacological properties, especially anti-inflammatory effects. In the present study, primary chondrocytes of IL-1β rats were used to simulate pathological environment of chondrocytes in OA, and to explore the effect of Myr on chondrocytes. It was found that Myr improved the viability and proliferation of chondrocytes, and also inhibited apoptosis in these cells. Moreover, Myr reduced the expressions of inflammatory factors, and inhibited inflammatory reactions in chondrocytes. These findings provide good experimental basis for the clinical application of Myr in the prevention and treatment of progressive degeneration of cartilage in OA.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Lane NE, Shidara K, Wise BL. Osteoarthritis year in review 2016: clinical. Osteoarthritis Cartilage 2017; 25: 209-215.
- Chang J, Liao Z, Lu M, Meng T, Han W, Ding C. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis Cartilage 2018; 26: 864-871.
- Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H, et al. Osteoarthritis. Lancet 2015; 386: 376-387.
- Frank M, Bwemero J, Kalunga D, Sangu W, Semeni S, Hamisi M, et al. OA60 Public health and palliative care mix; a ccpmedicine approach to reverse the overgrowing burden of non-communicable diseases in tanzania. BMJ Support Palliat Care 2015; 5: 19.
- Herrero-Beaumont G, Roman-Blas JA, Bruyère O, Cooper C, Kanis J, Maggi S, et al. Clinical settings in knee osteoarthritis: Pathophysiology guides treatment. Maturitas 2017; 96: 54-57.
- McAlindon TE, Bannuru RR, Sullivan M, Arden N, Berenbaum F, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22: 363-388.
- Bannuru RR, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 3: 1063-4584.
- Ahangarpour A, Oroojan AA, Khorsandi L, Kouchak M, Badavi M. Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell. Cell Stress Chaperones 2018; 23: 773-781.
- Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Å koda M, Višnić A. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 2015; 230: 21-29.
- Winekenstädde D, Angelis A, Waltenberger B, Schwaiger S, Tchoumtchoua J, König S, et al. Phytochemical profile of the aerial parts of Sedum sediforme and anti-inflammatory activity of myricitrin. Nat Prod Commun 2015; 10: 83-88.
- Huang Q, Gao B, Wang L, Hu YQ, Lu WG, Yang L, et al. Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines. Toxicol Appl Pharmacol 2014; 280: 550-560.
- Shimosaki S, Tsurunaga Y, Itamura H, Nakamura M. Anti-allergic effect of the flavonoid myricitrin from Myrica rubra leaf extracts in vitro and in vivo. Nat Prod Res 2011; 25: 374-380.
- Mei Y, Guan S, Zhang H, Han X, Li C, Teng F, et al. Priorities for osteoarthritis research in China. Osteoarthritis Cartilage 2018; 26: 220.
- Huang Z, Zhou M, Wang Q, Zhu M, Chen S, Li H. Mechanical and hypoxia stress can cause chondrocytes apoptosis through over-activation of endoplasmic reticulum stress. Arch Oral Biol 2017; 84: 125-132.
- Gu Y, Chen J, Meng Z, Yao J, Ge W, Chen K, et al. Diazoxide prevents H2O2-induced chondrocyte apoptosis and cartilage degeneration in a rat model of osteoarthritis by reducing endoplasmic reticulum stress. Biomed Pharmacother 2017; 95: 1886-1894.
- Jiang L, Wang W, He Q, Wu Y, Lu Z, Sun J, et al. Oleic acid induces apoptosis and autophagy in the treatment of Tongue Squamous cell carcinomas. Sci Rep 2017; 7: 11277.
- Rao Z, Wang S, Wang J. Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling. Biomed Pharmacother 2017; 90: 414-420.
- John T, Müller R, Oberholzer A, Zreiqat H, Kohl B, Ertel W, et al. Interleukin-10 modulates pro-apoptotic effects of TNF-α in human articular chondrocytes in vitro. Cytokine 2007; 40: 226-234.
- Van Doren SR. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol 2015; 44: 224-231.
- Rollin R, Marco F, Jover J, Garcia-Asenjo J, Rodriguez L, Lopez-Duran L, et al. Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls. Rheumatol Int 2008; 28: 757-764.
- Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors. Biochim Biophys Acta 2015; 1851: 414-421.
- Jayasuriya CT, Hu N, Li J, Lemme N, Terek R, Ehrlich MG, et al. Molecular characterization of mesenchymal stem cells in human osteoarthritis cartilage reveals contribution to the OA phenotype. Sci Rep 2018; 8: 7044.
References
Lane NE, Shidara K, Wise BL. Osteoarthritis year in review 2016: clinical. Osteoarthritis Cartilage 2017; 25: 209-215.
Chang J, Liao Z, Lu M, Meng T, Han W, Ding C. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis Cartilage 2018; 26: 864-871.
Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H, et al. Osteoarthritis. Lancet 2015; 386: 376-387.
Frank M, Bwemero J, Kalunga D, Sangu W, Semeni S, Hamisi M, et al. OA60 Public health and palliative care mix; a ccpmedicine approach to reverse the overgrowing burden of non-communicable diseases in tanzania. BMJ Support Palliat Care 2015; 5: 19.
Herrero-Beaumont G, Roman-Blas JA, Bruyère O, Cooper C, Kanis J, Maggi S, et al. Clinical settings in knee osteoarthritis: Pathophysiology guides treatment. Maturitas 2017; 96: 54-57.
McAlindon TE, Bannuru RR, Sullivan M, Arden N, Berenbaum F, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22: 363-388.
Bannuru RR, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 3: 1063-4584.
Ahangarpour A, Oroojan AA, Khorsandi L, Kouchak M, Badavi M. Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell. Cell Stress Chaperones 2018; 23: 773-781.
Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Å koda M, Višnić A. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 2015; 230: 21-29.
Winekenstädde D, Angelis A, Waltenberger B, Schwaiger S, Tchoumtchoua J, König S, et al. Phytochemical profile of the aerial parts of Sedum sediforme and anti-inflammatory activity of myricitrin. Nat Prod Commun 2015; 10: 83-88.
Huang Q, Gao B, Wang L, Hu YQ, Lu WG, Yang L, et al. Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines. Toxicol Appl Pharmacol 2014; 280: 550-560.
Shimosaki S, Tsurunaga Y, Itamura H, Nakamura M. Anti-allergic effect of the flavonoid myricitrin from Myrica rubra leaf extracts in vitro and in vivo. Nat Prod Res 2011; 25: 374-380.
Mei Y, Guan S, Zhang H, Han X, Li C, Teng F, et al. Priorities for osteoarthritis research in China. Osteoarthritis Cartilage 2018; 26: 220.
Huang Z, Zhou M, Wang Q, Zhu M, Chen S, Li H. Mechanical and hypoxia stress can cause chondrocytes apoptosis through over-activation of endoplasmic reticulum stress. Arch Oral Biol 2017; 84: 125-132.
Gu Y, Chen J, Meng Z, Yao J, Ge W, Chen K, et al. Diazoxide prevents H2O2-induced chondrocyte apoptosis and cartilage degeneration in a rat model of osteoarthritis by reducing endoplasmic reticulum stress. Biomed Pharmacother 2017; 95: 1886-1894.
Jiang L, Wang W, He Q, Wu Y, Lu Z, Sun J, et al. Oleic acid induces apoptosis and autophagy in the treatment of Tongue Squamous cell carcinomas. Sci Rep 2017; 7: 11277.
Rao Z, Wang S, Wang J. Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling. Biomed Pharmacother 2017; 90: 414-420.
John T, Müller R, Oberholzer A, Zreiqat H, Kohl B, Ertel W, et al. Interleukin-10 modulates pro-apoptotic effects of TNF-α in human articular chondrocytes in vitro. Cytokine 2007; 40: 226-234.
Van Doren SR. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol 2015; 44: 224-231.
Rollin R, Marco F, Jover J, Garcia-Asenjo J, Rodriguez L, Lopez-Duran L, et al. Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls. Rheumatol Int 2008; 28: 757-764.
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors. Biochim Biophys Acta 2015; 1851: 414-421.
Jayasuriya CT, Hu N, Li J, Lemme N, Terek R, Ehrlich MG, et al. Molecular characterization of mesenchymal stem cells in human osteoarthritis cartilage reveals contribution to the OA phenotype. Sci Rep 2018; 8: 7044.